Furthermore, a R. verniciflua Stockes extract, used as traditional medicine in Korea, exhibited lipid-lowering effects by lowering SREBP-1 and triglyceride levels, and promoting the activation of PPARs and AMPK in an in vitro model of non-alcoholic fatty liver disease [116]. The gene discussed is SREBF1; the disease is metabolic dysfunction-associated steatotic liver disease.